FDA guidance spurs adoption of change control plans for radiology AI devices - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA guidance spurs adoption of change control plans for radiology AI devices

Investigators examined adoption and public documentation of change control plans for FDA-cleared radiology AI devices.

  • By

  • Kathryn Wighton

  • September 16, 2026

  • 3 min

Share

  • 1

    Adoption of Predetermined Change Control Plans increased among radiology AI devices after FDA guidance was issued.

  • 2

    A systematic review evaluated FDA-cleared radiology AI/ML devices from 2015 to 2025 for PCCP use and public documentation transparency.

  • 3

    Among 1,394 FDA-listed AI/ML submissions, 1,080 (78%) were in radiology, with 99% cleared through the 510(k) pathway.

  • 4

    Public documentation for PCCP devices had a mean score of 5 on an 8-point rubric, indicating incomplete transparency.

  • 5

    The analysis highlighted limitations due to reliance on publicly available data and inconsistencies in FDA databases.

Original Source(s)

FDA guidance spurs adoption of change control plans for radiology AI devices

  • by Kathryn Wighton

  • September 16, 2026

Related Content

Peanuts may improve regional brain insulin response

A randomized crossover trial found changes in insulin-induced cerebral blood flow following 16 weeks of daily peanut consumption, although the connection to improved memory remains unclear.

RadCoT may improve LLM detection of report errors

The radiology-specific framework produced its largest gains in detecting interpretation and omission or insertion errors across 7 language models.

FDA approves FET-PET agent for glioma

The radioactive diagnostic drug is indicated in patients aged 1 month or older and is used in conjunction with other diagnostic evaluations.